Analysts’ Viewpoint
Livestock vaccines are crucial for preventing and controlling infectious/viral/bacterial diseases in farm animals, ensuring their productivity, health, and welfare. The global market for livestock vaccines is experiencing notable growth and is projected to continue expanding during the forecast period. Advances in vaccine development and biotechnology have led to the introduction of innovative and highly-effective vaccines for livestock population. Newer vaccine types, including recombinant vaccines and DNA vaccines, are gaining traction in the global livestock market.
The global livestock vaccines market is characterized by the presence of several key players, including multinational pharmaceutical companies, biotechnology firms, and regional manufacturers. These companies are focusing on research and development activities, strategic collaborations, and product launches to strengthen their market position and cater to the evolving needs of livestock producers.
Livestock farming is a key subsector of agriculture, specifically in developing regions such as India. It is a crucial livelihood source for farmers, contributing to the health and nutritional security of households and supporting agriculture along with supplementing incomes with employment opportunities.
The most efficient way of improving livestock productivity and reduce losses from disease mortality and morbidity is by monitoring health and controlling multiple diseases by utilizing effective vaccines. Research and development activities on veterinary biologicals worldwide have led to successful eradication of various diseases such as African horse sickness, contagious bovine pleuropneumonia, and rinderpest.
Vaccination helps protect animals from preventable diseases, reduces the need for invasive and stressful treatments, and ultimately improves their quality of life. The use of prophylactic vaccines controls numerous viral and bacterial diseases afflicting buffaloes and cattle, poultry, goats and sheep, and pigs.
Livestock diseases pose a considerable threat to welfare, productivity, and animal health, leading to substantial economic losses for farmers and the livestock industry as a whole. The huge need for effective preventive measures, including vaccines is a response to this growing challenge.
Diseases such as avian influenza, swine fever, foot-and-mouth disease, and numerous reproductive and respiratory diseases can have devastating clinical consequences for livestock animals. As per data published by World Organization for Animal Health, an intergovernmental organization, supporting and promoting animal disease control, FMD is projected to circulate in 77% of the global livestock population, specifically in the Middle East, Asia, Africa, and in several area of South America. Outbreaks of such diseases can result in reduced productivity, high mortality rates, public health risks, and trade restrictions. Vaccines play a crucial role in preventing and controlling the spread of these diseases, reducing the overall disease burden and its associated economic and social impacts.
Moreover, the globalization of trade and travel has increased the risk of disease transmission across borders. Livestock diseases can rapidly spread across countries and continents, causing widespread outbreaks and economic disruptions. Governments and regulatory bodies are increasingly recognizing the importance of vaccination in disease control, and implementing stringent biosecurity measures. These measures often include mandatory vaccination programs for livestock populations, further driving the demand for vaccines and ensuring livestock vaccines market progress.
Stakeholders in the livestock industry recognize the importance of vaccination as a key strategy to safeguard animal health, enhance productivity, and ensure sustainable livestock production, thus driving the livestock vaccines market growth.
Increase in emphasis on ethical livestock production practices and ensuring the welfare of animals throughout their lives are likely to offer lucrative opportunities for market expansion. Vaccination plays a crucial role in promoting animal welfare by preventing and controlling infectious diseases that can cause significant suffering and compromise the overall well-being of livestock.
Animal welfare concerns are driven by societal awareness and consumer demand for ethically produced animal products. Consumers are becoming more conscious of the conditions in which animals are raised and the impact of livestock production on animal welfare. They are actively seeking out products from producers who prioritize animal health and welfare, including the use of preventive measures like vaccination.
Vaccination is a proactive approach to disease prevention, reducing the need for antimicrobial treatments and minimizing the stress and discomfort experienced by animals due to illness. By effectively preventing diseases, vaccines contribute to better overall health and reduced suffering in livestock populations. This aligns with the principles of animal welfare, which emphasize providing animals with a life free from pain, distress, and disease.
As the demand for ethically produced animal products continues to rise, the use of vaccines as a preventive measure will likely be prioritized, fueling the livestock vaccines market size.
The livestock vaccines market segmentation in terms of vaccine type includes bovine vaccine, poultry vaccine, porcine vaccine, and others. The bovine vaccine segment accounted for major share of the global market in 2022.
Cattle are one of the most widely raised livestock species globally, with a large population spread across various regions. China, India, and Brazil account for approximately 64% of the global cattle inventory. The sheer number of cattle necessitates extensive disease prevention measures, including vaccination. The high demand for bovine vaccines is driven by the need to protect and maintain the health of this significant livestock population.
Any disease outbreak among cattle can have severe economic consequences for farmers and the livestock industry. Bovine vaccines are essential tools in reducing disease-related losses, enhancing productivity, and ensuring the production of safe and high-quality meat and dairy products.
Multiple nations have established regulatory frameworks and mandatory vaccination programs for cattle to control and prevent specific diseases. For instance, foot-and-mouth disease is a highly contagious viral disease that requires strict vaccination programs to prevent its spread. Compliance with these regulations drives the demand for bovine vaccines.
Continued focus on cattle health and welfare, along with the growth in demand for animal protein, is expected to sustain the prominence of the bovine vaccine segment in the coming years.
The livestock vaccines market analysis based on end-user includes veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment is projected to be highly lucrative during the forecast period.
Specialized infrastructure and expertise in animal care of veterinary hospitals, as well as state-of-the-art equipment and experienced healthcare professionals allows for accurate diagnosis and appropriate veterinary patient selection, ensuring optimal outcomes.
Veterinary hospitals provide a convenient and reliable setting for livestock owners to access vaccination services. Availability of comprehensive healthcare services in one location makes veterinary hospitals an attractive choice for livestock owners.
The market for livestock vaccines varies across regions owing to differences in disease incidence, livestock production systems, economic factors, and regulatory policies.
According to the latest livestock vaccines market forecast, North America dominated the global landscape in 2022 and is expected to continue its dominance.
Robust government policies are expected to drive the North America livestock vaccines market in the next few years. In July 2023, the Government of Canada announced plans to create a vaccine bank for FMD in animals. Strong presence of prominent players, including Merck Animal Health, Zoetis Animal Health, and Elanco and their effective strategies are driving market dynamics in the region.
However, Asia Pacific is the fastest growing region in the livestock vaccines market, with China being the largest contributor to market revenue. Rise in prevalence of livestock animal diseases, specifically in Southeast Asian countries, is driving market statistics in Asia Pacific.
The global livestock vaccines market report provides profiles of prominent players operating in the animal health sector. These include Dechra Pharmaceuticals PLC, Ceva Santé Animale, Elanco, Merck & Co., Inc., Zoetis Services LLC, Boehringer Ingelheim International GmbH., Virbac, Biogénesis Bagó, Ourofino Saúde Animal, and VETAL Animal Health Products, Inc. These players engage in mergers & acquisitions, strategic collaborations, and new product launches to expand presence and gain significant livestock vaccines industry share.
The livestock vaccine market research report profiles the top players based on various factors including company overview, financial summary, strategies, product portfolio, segments, and recent advancements.
| Attribute | Detail |
|---|---|
| Size in 2022 | US$ 5.4 Bn |
| Forecast (Value) in 2031 | More than US$ 9.4 Bn |
| Growth Rate (CAGR) | 6.4% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 5.4 Bn in 2022
It is projected to reach more than US$ 9.4 Bn by 2031
The business is anticipated to grow at a CAGR of 6.4% from 2023 to 2031
Rise in prevalence of livestock diseases, and increase in demand for effective preventive care such as recombinant vaccines
North America is projected to account for major share during the forecast period
Dechra Pharmaceuticals PLC, Ceva Santé Animale, Elanco, Merck & Co., Inc., Zoetis Services LLC, Boehringer Ingelheim International GmbH, Virbac, Biogénesis Bagó, Ourofino Saúde Animal, and VETAL Animal Health Products, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Livestock Vaccines Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Livestock Vaccines Market Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Disease Epidemiology
5.2. Pipeline Analysis
5.3. Key Industry Events
5.4. COVID-19 Pandemic Impact on Industry
6. Global Livestock Vaccines Market Analysis and Forecast, by Vaccine Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Vaccine Type, 2023–2031
6.3.1. Bovine Vaccine
6.3.2. Poultry Vaccine
6.3.3. Porcine Vaccine
6.3.4. Others
6.4. Market Attractiveness Analysis, by Vaccine Type
7. Global Livestock Vaccines Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2023–2031
7.3.1. Live Attenuated Vaccine
7.3.2. Inactivated Vaccine
7.3.3. Recombinant Vaccine
7.3.4. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Livestock Vaccines Market Analysis and Forecasts, by Route of Administration
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Route of Administration, 2023–2031
8.3.1. Oral
8.3.2. Parenteral
8.3.3. Others
8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Livestock Vaccines Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2023–2031
9.3.1. Veterinary Hospitals
9.3.2. Veterinary Clinics
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Livestock Vaccines Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2023–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Livestock Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Vaccine Type, 2023–2031
11.2.1. Bovine Vaccine
11.2.2. Poultry Vaccine
11.2.3. Poultry Vaccine
11.2.4. Others
11.3. Market Value Forecast, by Technology, 2023–2031
11.3.1. Live Attenuated Vaccine
11.3.2. Inactivated Vaccine
11.3.3. Recombinant Vaccine
11.3.4. Others
11.4. Market Value Forecast, by Route of Administration, 2023–2031
11.4.1. Oral
11.4.2. Parenteral
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2023–2031
11.5.1. Veterinary Hospitals
11.5.2. Veterinary Clinics
11.5.3. Others
11.6. Market Value Forecast, by Country, 2023–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Vaccine Type
11.7.2. By Technology
11.7.3. By Route of Administration
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe Livestock Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Vaccine Type, 2023–2031
12.2.1. Bovine Vaccine
12.2.2. Poultry Vaccine
12.2.3. Porcine Vaccine
12.2.4. Others
12.3. Market Value Forecast, by Technology, 2023–2031
12.3.1. Live Attenuated Vaccine
12.3.2. Inactivated Vaccine
12.3.3. Recombinant Vaccine
12.3.4. Others
12.4. Market Value Forecast, by Route of Administration, 2023–2031
12.4.1. Oral
12.4.2. Parenteral
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2023–2031
12.5.1. Veterinary Hospitals
12.5.2. Veterinary Clinics
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2023–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Vaccine Type
12.7.2. By Technology
12.7.3. By Route of Administration
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Livestock Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Vaccine Type, 2023–2031
13.2.1. Bovine Vaccine
13.2.2. Poultry Vaccine
13.2.3. Porcine Vaccine
13.2.4. others
13.3. Market Value Forecast, by Technology, 2023–2031
13.3.1. Live Attenuated Vaccine
13.3.2. Inactivated Vaccine
13.3.3. Recombinant Vaccine
13.3.4. Others
13.4. Market Value Forecast, by Route of Administration, 2023–2031
13.4.1. Oral
13.4.2. Parenteral
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2023–2031
13.5.1. Veterinary Hospitals
13.5.2. Veterinary Clinics
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2023–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Vaccine Type
13.7.2. By Technology
13.7.3. By Route of Administration
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Livestock Vaccines Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Vaccine Type, 2023–2031
14.2.1. Bovine Vaccine
14.2.2. Poultry Vaccine
14.2.3. Porcine Vaccine
14.2.4. Others Vaccine
14.3. Market Value Forecast, by Technology, 2023–2031
14.3.1. Live Attenuated Vaccine
14.3.2. Inactivated Vaccine
14.3.3. Recombinant Vaccine
14.3.4. Others
14.4. Market Value Forecast, by Route of Administration, 2023–2031
14.4.1. Oral
14.4.2. Parenteral
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2023–2031
14.5.1. Veterinary Hospitals
14.5.2. Veterinary Clinics
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2023–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Vaccine Type
14.7.2. By Technology
14.7.3. By Route of Administration
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Livestock Vaccines Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Vaccine Type, 2023–2031
15.2.1. Bovine Vaccine
15.2.2. Poultry Vaccine
15.2.3. Porcine Vaccine
15.2.4. Others
15.3. Market Value Forecast, by Technology, 2023–2031
15.3.1. Live Attenuated Vaccine
15.3.2. Inactivated Vaccine
15.3.3. Recombinant Vaccine
15.3.4. Others
15.4. Market Value Forecast, by Route of Administration, 2023–2031
15.4.1. Oral
15.4.2. Parenteral
15.4.3. Others
15.5. Market Value Forecast, by End-user, 2023–2031
15.5.1. Veterinary Hospitals
15.5.2. Veterinary Clinics
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2023–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Vaccine Type
15.7.2. By Technology
15.7.3. By Route of Administration
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Dechra Pharmaceuticals PLC
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Ceva Santé Animale
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Elanco
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Merck & Co., Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Zoetis Services LLC
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Boehringer Ingelheim International GmbH.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Virbac
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Biogénesis Bagó
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Ourofino Saúde Animal
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. VETAL Animal Health Products, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Other prominent Players
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
List of Tables
Table 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 02: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 03: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 04: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 05: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Region, 2023–2031
Table 06: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country, 2023–2031
Table 07: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 08: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 09: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 10: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 11: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 12: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 13: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 14: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 15: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 16: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 17: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 18: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 19: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 20: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 21: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 22: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 23: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 24: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 25: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 26: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 27: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 28: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 29: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 30: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
List of Figures
Figure 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 02: Global Livestock Vaccines Market Value Share, by Vaccine Type, 2022
Figure 03: Livestock Vaccines Market Value Share, by Technology, 2022
Figure 04: Livestock Vaccines Market Value Share, by Route of Administration, 2022
Figure 05: Global Livestock Vaccines Market Value Share, by End-user, 2022
Figure 06: Global Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 07: Global Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 08: Global Livestock Vaccines Market Revenue (US$ Mn), by Bovine Vaccine , 2023–2031
Figure 09: Global Livestock Vaccines Market Revenue (US$ Mn), by Poultry Vaccine, 2023–2031
Figure 10: Global Livestock Vaccines Market Revenue (US$ Mn), by Porcine Vaccine, 2023–2031
Figure 11: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023–2031
Figure 12: Global Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 13: Global Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 14: Global Livestock Vaccines Market Value (US$ Mn), by Live Attenuated Vaccine, 2023‒2031
Figure 15: Global Livestock Vaccines Market Value (US$ Mn), by Inactivated Vaccine, 2023‒2031
Figure 16: Global Livestock Vaccines Market Value (US$ Mn), by Recombinant Vaccine, 2023‒2031
Figure 17: Global Livestock Vaccines Market Value (US$ Mn), by Others, 2023‒2031
Figure 18: Global Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 19: Global Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 20: Global Livestock Vaccines Market Revenue (US$ Mn), by Oral , 2023–2031
Figure 21: Global Livestock Vaccines Market Revenue (US$ Mn), by Parenteral, 2023–2031
Figure 22: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023–2031
Figure 23: Global Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: Global Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 25: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Hospitals, 2023–2031
Figure 26: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Clinics, 2023–2031
Figure 27: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023–2031
Figure 28: Global Livestock Vaccines Market Value Share Analysis, by Region, 2022 and 2031
Figure 29: Global Livestock Vaccines Market Attractiveness Analysis, by Region, 2023–2031
Figure 30: North America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 31: North America Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
Figure 32: North America Livestock Vaccines Market Attractiveness Analysis, by Country, 2023–2031
Figure 33: North America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 34: North America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 35: North America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 36: North America Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 37: North America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 38: North America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 39: North America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: North America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 41: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 42: Europe Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
Figure 43: Europe Livestock Vaccines Market Attractiveness Analysis, by Country, 2023–2031
Figure 44: Europe Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 45: Europe Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 46: Europe Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 47: Europe Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 48: Europe Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 49: Europe Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 50: Europe Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Europe Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 52: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 53: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 54: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 55: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 56: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 57: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 58: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 59: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 60: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 61: Asia Pacific Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 63: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 64: Latin America Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 65: Latin America Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 66: Latin America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 67: Latin America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 68: Latin America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 69: Latin America Livestock Vaccines Market Attractiveness Analysis, by Technology, 2023–2031
Figure 70: Latin America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 71: Latin America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 72: Latin America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Latin America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 74: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 75: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 76: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 77: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 78: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 79: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 80: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 81: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 82: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Route of Administration, 2023–2031
Figure 83: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 84: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 85: Global Livestock Vaccines Market Share Analysis By Company (2022)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Livestock Vaccines Market
